Fact CheckerSign in

NCT07194902Recruiting

HIV Self-testing for Partners of HIV-uninfected Postpartum Women

HIV Self-testing for Partners of HIV-uninfected Postpartum Women to Facilitate PrEP and Antiretroviral Therapy Uptake to Promote HIV Treatment and Prevention

Source: ClinicalTrials.gov · Last updated 23 Mar 2026

Brief summary (registry, in English)

The purpose of this study is to test the feasibility and acceptability of a combination intervention to promote HIV self-testing (HIVST) for Partners and PrEP uptake for HIV-uninfected Postpartum Women ("H4P"). H4P includes evidence-based cognitive behavioral therapy (CBT) strategies, such as communication skills training, motivational interviewing, and problem-solving. The investigators will conduct a randomized pilot trial of the H4P intervention to evaluate the feasibility, acceptability, and preliminary effectiveness of a multi-step PrEP uptake and HIV self-test kit intervention for postpartum HIV-uninfected women (N = 60 and their male partners) who report a partner of unknown serostatus, and their partners, in the province of KwaZulu-Natal, South Africa.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
120 (estimated)
First submitted
11 Sept 2025
Start date
Mar 2026
Primary completion date
Aug 2026
Lead sponsor
Massachusetts General Hospital
Diseases
HIV
NCT number
NCT07194902

What you commit to

  • Study type: Interventional
  • Planned participants: 120
  • From Mar 2026 to the primary completion date, Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Female Inclusion Criteria:
  • woman
  • Age ≥18
  • ≥30 weeks pregnant per medical record due date
  • non-reactive third trimester HIV test (verified from their antenatal care chart)
  • reporting at least one unknown-serostatus partner
  • fluent in English or isiZulu
  • willing to give researchers permission to contact them for repeated assessments
  • able to provide informed consent
    • Male Inclusion Criteria: partners meeting the inclusion criteria as described above, and who complete verification questions to confirm their identity and status as the partners of the enrolled female participants. Additional inclusion criteria for men include:
  • man
  • Age ≥18
  • partner of enrolled women, confirmed via couples verification tool
  • fluent in English or isiZulu
  • willing to give researchers permission to contact them
  • able to provide informed consent.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Wits MatCH Research Unit
Coordinator of this site? Confirm its status
DurbanSouth AfricaRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.